Sora concept stocks strengthened, Huace Film and Television rose by more than 10%, Sora concept stocks strengthened, Huace Film and Television rose by more than 10%, Fengyuzhu and Tianyu Entertainment both went up, and Borui Communication, Jincai Internet, Yuanlongyatu and Huayang Lianzhong followed suit.Pinduoduo's concept oscillates higher, which is worth buying up by over 10%, and Pinduoduo's concept oscillates higher, which is worth buying up by over 10%. If Yuchen has a daily limit, Yuanlong Yatu, Xuan Ya International, rebate technology, online and offline will follow suit.According to sources, Keppel and Sovico Group are discussing submarine cables between Singapore and Vietnam.
The South Korean prosecutor summoned Guo Zhonggen, the commander of the special operations before the investigation. On the 13th local time, the South Korean prosecutor summoned Guo Zhonggen, the commander of the special operations before the investigation.Singapore iron ore futures fell 2.4%, almost erasing the gains this week.Turkish regulators blocked access to dozens of cryptocurrency exchanges, and the Turkish Capital Markets Board listed websites that allegedly provided unauthorized cryptoasset services to Turkish customers.
Port hedland's iron ore exports increased to 48.755 million tons in November.Japan's final industrial output value in October increased by 2.8% month-on-month and 1.4% year-on-year.CMB International: Upgraded the target price of WuXi Bio to HK$ 22.88, optimistic about the company's valuation and performance repair. CMB International published a report, predicting that the US Biosafety Act will fail with high probability, which will help WuXi Bio to achieve continuous performance growth in a relatively stable business environment. With the recovery of global biomedical financing, we are optimistic about the company's valuation and performance repair. According to the report, the NDAA in FY 2025 does not include the Biosafety Act, and the legislation of the Biosafety Act failed with high probability. On December 7, the US Senate and the House Armed Services Committee announced the National Defense Authorization Act (NDAA) for fiscal year 2025, which was finally negotiated by the committees of the two houses. The Biosafety Act was not included in the amendment of NDAA in FY 2025, which means that the Biosafety Act failed to pass the legislative path of joining NDAA. The Biosafety Act can still promote separate legislation, but considering that the window of the current US Congress session is less than two weeks, the Bank believes that the success rate of separate legislation is extremely low. CMB International maintained the "Buy" rating of Yaoming Bio, and its target price rose from HK$ 13.58 to HK$ 22.88. It is estimated that the company's revenue will increase by 7.1%/12.4%/ 13.9% from 2024 to 2026, and its adjusted net profit will increase by 0.8%/11.1%/13.4% respectively.
Strategy guide 12-14
Strategy guide
12-14
Strategy guide